27. November 2020
Global Data Hub – 10 von 17 Insights
Privacy issues around health data have come into sharp relief during the COVID-19 pandemic, focused on the race to develop an effective test and trace system and a vaccine.
Whether health data is processed by medical devices, in databases or paper files, protection of this sensitive information is vital. We look at some key regulatory requirements in the UK, France and Germany:
Mary Rendle looks at the regulatory framework for medical devices processing NHS health data.
Vin Bange and Debbie Heywood consider the exemptions and restrictions that apply to health data-related subject access requests.
Thanos Rammos looks at the new regulatory regime for digital healthcare and 'apps by prescription' in Germany.
Jo Joyce looks at the privacy issues involved in developing contact tracing apps and whether they impact their ultimate success.
Sally Annereau looks at the proposed changes to the Caldicott Principles which aim to maintain future relevance
Nolwenn Vignaud looks at rules around processing health data in France and at their impact on transfers of health data to the USA.
Helen Farr looks at the data protection implications of the EU Whistleblowing Directive and whistleblower hotlines more generally.
11. July 2022
von Helen Farr
Anna Taylor and Jo Joyce look at the data sharing requirements for the proposed pensions dashboard and resulting data protection considerations.
17. May 2022
von Anna Taylor, Jo Joyce
15. March 2022
von mehreren Autoren
14. February 2022
von mehreren Autoren
8. November 2021
von Debbie Heywood
9. August 2021
von Debbie Heywood
9. October 2020
von mehreren Autoren
11. February 2019
von Debbie Heywood
6. March 2020
von mehreren Autoren
von Debbie Heywood
von Debbie Heywood